Other Clinical Trial - Myocardial Work for Prediction of Left Ventricular

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The study intends to investigate the alteration of regional myocardial work in patients with acute anterior myocardial infarction underwent primary percutaneous coronary intervention (PCI), and compare the distribution of regional myocardial work in patients with/without early remodeling at acute phase and 3-month follow-up.

See also
	Status	Clinical Trial	Phase
	Not yet recruiting	`NCT04157868` - Early rhBNP on Myocardial Work in Patients With STEMI	Phase 4

NCT number	NCT05107102
Study type	Observational
Source	RenJi Hospital
Contact
Status	Completed
Phase
Start date	September 10, 2019
Completion date	August 30, 2021

Myocardial Work for Prediction of Left Ventricular Remodeling in Patients With STEMI

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms